Cargando…
Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease
BACKGROUND: The aim of this study was to investigate the risk factors of low vision in type 2 diabetic patients and the prevalence of ischemic heart diseases and nephropathy for different visual acuities. METHODS: In this cross-sectional study, data from 738 type 2 diabetic patients including eviden...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252768/ https://www.ncbi.nlm.nih.gov/pubmed/22247728 |
_version_ | 1782220667907735552 |
---|---|
author | Horri, Negar Farmani, Mahboube Ghassami, Mahmoud Haghighi, Sassan Amini, Massoud |
author_facet | Horri, Negar Farmani, Mahboube Ghassami, Mahmoud Haghighi, Sassan Amini, Massoud |
author_sort | Horri, Negar |
collection | PubMed |
description | BACKGROUND: The aim of this study was to investigate the risk factors of low vision in type 2 diabetic patients and the prevalence of ischemic heart diseases and nephropathy for different visual acuities. METHODS: In this cross-sectional study, data from 738 type 2 diabetic patients including evidences for nephropathy and ischemic heart disease, demographic characteristics, blood pressure and body mass index were collected, and then patients were divided into 3 groups based on their best corrected visual acuity in the better-seeing eye. Analysis of variance was used to compare basic characteristics according to different levels of visual acuity. RESULTS: The prevalence of blindness and low vision was 5.5% and 13.3% respectively, and as age, duration of diabetes, systolic blood pressure and body mass index increased, the visual acuity decreased. The prevalence of hypertension and obesity in patients with visual disabilities was significantly higher than in patients with not impaired visions (p = 0.008 and p = 0.02, respectively). We also found that with greater decline in visual acuity, the prevalence of neph-ropathy and ischemic heart diseases increased. CONCLUSIONS: The factors related to retinopathy play a role in affecting the degree of visual impairment in diabetic patients. Therefore, controlling risk factors can be useful in decreasing impairment of vision and blindness. |
format | Online Article Text |
id | pubmed-3252768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-32527682012-01-13 Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease Horri, Negar Farmani, Mahboube Ghassami, Mahmoud Haghighi, Sassan Amini, Massoud J Res Med Sci Original Article BACKGROUND: The aim of this study was to investigate the risk factors of low vision in type 2 diabetic patients and the prevalence of ischemic heart diseases and nephropathy for different visual acuities. METHODS: In this cross-sectional study, data from 738 type 2 diabetic patients including evidences for nephropathy and ischemic heart disease, demographic characteristics, blood pressure and body mass index were collected, and then patients were divided into 3 groups based on their best corrected visual acuity in the better-seeing eye. Analysis of variance was used to compare basic characteristics according to different levels of visual acuity. RESULTS: The prevalence of blindness and low vision was 5.5% and 13.3% respectively, and as age, duration of diabetes, systolic blood pressure and body mass index increased, the visual acuity decreased. The prevalence of hypertension and obesity in patients with visual disabilities was significantly higher than in patients with not impaired visions (p = 0.008 and p = 0.02, respectively). We also found that with greater decline in visual acuity, the prevalence of neph-ropathy and ischemic heart diseases increased. CONCLUSIONS: The factors related to retinopathy play a role in affecting the degree of visual impairment in diabetic patients. Therefore, controlling risk factors can be useful in decreasing impairment of vision and blindness. Medknow Publications & Media Pvt Ltd 2011-03 /pmc/articles/PMC3252768/ /pubmed/22247728 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Horri, Negar Farmani, Mahboube Ghassami, Mahmoud Haghighi, Sassan Amini, Massoud Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease |
title | Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease |
title_full | Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease |
title_fullStr | Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease |
title_full_unstemmed | Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease |
title_short | Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease |
title_sort | visual acuity in an iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252768/ https://www.ncbi.nlm.nih.gov/pubmed/22247728 |
work_keys_str_mv | AT horrinegar visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease AT farmanimahboube visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease AT ghassamimahmoud visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease AT haghighisassan visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease AT aminimassoud visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease |